Evidence map›Paper›PMID 26684823›Full record

ReviewAIDS (London, England)2016

Dosing antiretroviral medication when crossing time zones: a review.

Joseph M Lewis, Alain Volny-Anne, Catriona Waitt, Marta Boffito, Saye Khoo

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in AIDS (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Adherence and Health Problems in Thai Travellers Living with HIV.Tropical medicine and infectious disease · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joseph M LewisaTropical and Infectious Diseases Unit, Royal Liverpool University Hospital bWellcome Trust Liverpool Glasgow Centre for Global Health Research, University of Liverpool, Liverpool, UK cEuropean AIDS Treatment Group, Brussels, Belgium dDepartment of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool eSt Stephen's Centre, Chelsea & Westminster Foundation Trust, London, UK.
Alain Volny-Anne
Catriona Waitt
Marta Boffito
Saye Khoo

Funding

Wellcome Trust 100890Wellcome Trust 109105Wellcome Trust 109105/Z/15/Z
6 · The paper itself

Abstract

International tourism continues to increase worldwide, and people living with HIV and their clinicians are increasingly confronted with the problem of how to dose antiretroviral therapy during transmeridian air travel across time zones. No guidance on this topic currently exists. This review is a response to requests from patient groups for clear, practical and evidence-based guidance for travelling on antiretroviral therapy; we present currently available data on the pharmacokinetic forgiveness and toxicity of various antiretroviral regimens, and synthesize this data to provide guidelines on how to safely dose antiretrovirals when travelling across time zones.

Indexed as

TravelAnti-Retroviral AgentsHIV InfectionsHumansAnti-Retroviral Agents

Identifiers

PMID26684823
PMCPMC4697953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.